|
C1ORF172 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.36389965566775E-10 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.92750000005404E-06 |
| Normal-vs-Stage2 |
8.23960000229107E-09 |
| Normal-vs-Stage3 |
1.10830233879256E-11 |
| Normal-vs-Stage4 |
8.54990001020184E-09 |
| Stage1-vs-Stage2 |
1.638400E-02 |
| Stage1-vs-Stage3 |
5.618500E-04 |
| Stage1-vs-Stage4 |
1.959840E-03 |
| Stage2-vs-Stage3 |
5.488000E-01 |
| Stage2-vs-Stage4 |
1.799980E-01 |
| Stage3-vs-Stage4 |
3.094200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.9182999633216E-09 |
| Normal-vs-AfricanAmerican |
8.42439999981792E-07 |
| Normal-vs-Asian |
1.6255899999984E-05 |
| Caucasian-vs-AfricanAmerican |
2.728400E-01 |
| Caucasian-vs-Asian |
1.415630E-01 |
| AfricanAmerican-vs-Asian |
8.871900E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.44130000157006E-08 |
| Normal-vs-Female |
2.76350053951546E-10 |
| Male-vs-Female |
4.948100E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.87789999994692E-07 |
| Normal-vs-Extreme_Weight |
5.19680000143907E-08 |
| Normal-vs-Obese |
1.16389999860189E-08 |
| Normal-vs-Extreme_Obese |
6.946000E-02 |
| Normal_Weight-vs-Extreme_Weight |
4.749600E-01 |
| Normal_Weight-vs-Obese |
8.476000E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.891600E-01 |
| Extreme_Weight-vs-Obese |
2.825600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.718800E-01 |
| Obese-vs-Extreme_Obese |
1.845360E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.985800E-04 |
| Normal-vs-Age(41-60Yrs) |
1.01860000434328E-08 |
| Normal-vs-Age(61-80Yrs) |
4.78969996997591E-09 |
| Normal-vs-Age(81-100Yrs) |
2.27370000049909E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.064600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.763800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.193000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.727600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.011160E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.049970E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.94580000004263E-06 |
| Normal-VS-Type2 PRCC |
9.99200722162641E-15 |
| Normal-VS-KIRP CIMP |
2.32290000012902E-07 |
| Normal-VS-Unclassified PRCC |
2.96459967685792E-10 |
| Type1 PRCC-VS-Type2 PRCC |
5.56520385330828E-11 |
| Type1 PRCC-VS-KIRP CIMP |
2.898800E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
8.04770000000232E-05 |
| Type2 PRCC-VS-KIRP CIMP |
9.980200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.913600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.215600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.11940021088708E-10 |
| Normal-vs-N1 |
7.71493979812021E-13 |
| Normal-vs-N2 |
5.93400000026278E-07 |
| N0-vs-N1 |
7.137900E-02 |
| N0-vs-N2 |
5.444100E-02 |
| N1-vs-N2 |
1.337820E-01 |
|
|
